# Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

> **NCT00241358** · PHASE1,PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 92 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute
- Leukemia, Myelogenous, Chronic
- Leukemia, Lymphoblastic, Acute
- Lymphocytic Leukemia, Chronic
- Myelodysplastic Syndromes
- Multiple Myeloma
- Lymphoma, Non-Hodgkin
- Hodgkin Disease

## Interventions

- **DRUG:** AMD3100
- **PROCEDURE:** Stem Cell Transplant

## Key facts

- **NCT ID:** NCT00241358
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241358, "Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00241358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*